Cited by 192Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

NMDA receptor dysfunction in autism spectrum disorders

Lee, Eun-Jae, Choi, Su Yeon, Kim, Eunjoon·2015·Current Opinion in Pharmacology

Abstract

Abnormalities and imbalances in neuronal excitatory and inhibitory synapses have been implicated in diverse neuropsychiatric disorders including autism spectrum disorders (ASDs). Increasing evidence indicates that dysfunction of NMDA receptors (NMDARs) at excitatory synapses is associated with ASDs. In support of this, human ASD-associated genetic variations are found in genes encoding NMDAR subunits. Pharmacological enhancement or suppression of NMDAR function ameliorates ASD symptoms in humans. Animal models of ASD display bidirectional NMDAR dysfunction, and correcting this deficit rescues ASD-like behaviors. These findings suggest that deviation of NMDAR function in either direction contributes to the development of ASDs, and that correcting NMDAR dysfunction has therapeutic potential for ASDs.

Integrity signals

Registry

Crossref · 10.1016/j.coph.2014.10.007

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lee, E.-J., Choi, S. Y., & Kim, E.
Affiliations
Korea Advanced Institute of Science and Technology (KR)
Corresponding author
Kim, Eunjoon
Venue
Current Opinion in Pharmacology
Publisher
Elsevier BV
Published
2015-02
Volume
20
Pages
8-13
ISSN
1471-4892 (ISSN-L)
OpenAlex
W2015029726
Cited by
192
References
50
Citations by year
2026: 9 · 2025: 16 · 2024: 13 · 2023: 9 · 2022: 24 · 2021: 12 · 2020: 22 · 2019: 18 · 2018: 23 · 2017: 17 · 2016: 22 · 2015: 6 · 2012: 1
FWCI
2.25
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Institute for Basic Science
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
NMDA receptor dysfunction, autism spectrum disorder, excitatory synapses, excitation-inhibition balance, NMDA receptor subunits, animal models of autism, NMDA receptor modulation, therapeutic potential
MeSH terms
Animals, Child Development Disorders, Pervasive, Disease Models, Animal, Humans, Synapses, Genetic Variation, Receptors, N-Methyl-D-Aspartate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review